Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
T Cell Activation
100%
Interleukin-7 (IL-7)
100%
COVID-19
100%
ELISPOT
37%
Cellular Technology
37%
ImmunoSpot
37%
Virus
25%
Peripheral Blood Mononuclear Cells
25%
Systemic Inflammation
12%
Interferon-α (IFN-α)
12%
Adaptive Immune Response
12%
Immune Suppression
12%
Interferon Production
12%
T Cells
12%
Hospitalized Patients
12%
CD28
12%
Cytokine Production
12%
Cell-derived
12%
Single Center
12%
Incubation
12%
One Dose
12%
Shaker
12%
Specific Patient
12%
Activated T Cells
12%
Cleveland
12%
Corticosteroid Therapy
12%
Fresh Whole Blood
12%
Cellular Immune Response
12%
Acute Severe
12%
Recombinant Human interleukin-7
12%
Immunomodulatory Therapy
12%
Medical ICU
12%
Non-parametric Analysis
12%
In Vitro Effect
12%
Standard-of-care Therapy
12%
Friedman Test
12%
Global Pandemic
12%
Dexamethasone Sodium Phosphate
12%
Functional Immune Response
12%
Functional Precision Medicine
12%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
12%
Academic Hospital
12%
Medical Wards
12%
Spot number
12%
Professional Software
12%
Medicine and Dentistry
In Vitro
100%
T Cell
100%
Cell Function
100%
Interleukin 7
100%
Dexamethasone
100%
COVID-19
100%
Enzymes
37%
Peripheral Blood Mononuclear Cell
25%
Virus
25%
Interferon
12%
Immune Response
12%
Immunosuppressive Treatment
12%
Analysis of Variance
12%
Interferon Production
12%
Personalized Medicine
12%
Incubation
12%
Cytokine Production
12%
Corticosteroid Therapy
12%
Student T Test
12%
Immune Function
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
CD3 Antigen
12%
Inflammation
12%
Friedman Test
12%
Dexamethasone Sodium Phosphate
12%
Pathogenesis
12%
Immunology and Microbiology
T Cell
100%
Cell Function
100%
Dexamethasone
100%
Interleukin 7
100%
COVID-19
100%
In Vitro
100%
Peripheral Blood Mononuclear Cell
25%
Virus
25%
interferon
12%
Immune Response
12%
Interferon Production
12%
CD28
12%
Cytokine Production
12%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Systemic Inflammation
12%
CD3 Antigen
12%